Compound details
Physagulin A
| Compound ID | CDAMM01714 |
|---|---|
| Common name | Physagulin A | IUPAC name | [15-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-12-hydroxy-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadeca-4,14-dien-13-yl] acetate |
| Molecular formula | C30H38O7 |
| Retention time | 3.26 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 511.266 | Theoretical mz | 511.269 |
| Error | 5.63 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.4545 |
| Inchi key | GPTVOZHQPZXWDW-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C1OC(CC(=C1C)C)C(C2=CC(OC(=O)C)C3(O)C4CC5OC65CC=CC(=O)C6(C)C4CCC23C)C |
| Superclass | Lipids and lipid-like molecules |
| Class | Steroids and steroid derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P06241 | FYN | Tyrosine-protein kinase FYN | T17980 | SwissTargetPrediction |
| P00533 | EGFR | Epidermal growth factor receptor erbB1 | T59328 | SwissTargetPrediction |
| P29274 | ADORA2A | Adenosine A2a receptor | T77365 | SwissTargetPrediction |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase-1 | T06273 | SwissTargetPrediction |
| P00797 | REN | Renin | T61622 | SwissTargetPrediction |
| P41594 | GRM5 | Metabotropic glutamate receptor 5 | T99347 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SwissTargetPrediction |
| P34913 | EPHX2 | Epoxide hydratase | T35734 | SwissTargetPrediction |
| P28223 | HTR2A | Serotonin 2a (5-HT2a) receptor | T32060 | SwissTargetPrediction |
| P35354 | PTGS2 | Cyclooxygenase-2 | T66665 | SwissTargetPrediction |
| P10275 | AR | Androgen Receptor | T11211 | SwissTargetPrediction |
| P45983 | MAPK8 | c-Jun N-terminal kinase 1 | T40097 | SwissTargetPrediction |
| P08235 | NR3C2 | Mineralocorticoid receptor | T72168 | SwissTargetPrediction |
| P04150 | NR3C1 | Glucocorticoid receptor | T40016 | SwissTargetPrediction |
| P06401 | PGR | Progesterone receptor | T22939 | SwissTargetPrediction |
| O75469 | NR1I2 | Pregnane X receptor | T82702 | SwissTargetPrediction |
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SwissTargetPrediction |
| P07339 | CTSD | Cathepsin D | T67102 | SwissTargetPrediction |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SwissTargetPrediction |
| P28845 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | T65200 | SwissTargetPrediction |
| P06746 | POLB | DNA polymerase beta (by homology) | T06958 | SwissTargetPrediction |
| P08254 | MMP3 | Matrix metalloproteinase 3 | T86702 | SwissTargetPrediction |
| P08069 | IGF1R | Insulin-like growth factor I receptor | T48069 | SwissTargetPrediction |
| P35462 | DRD3 | Dopamine D3 receptor | T02551 | SwissTargetPrediction |
| P11309 | PIM1 | Serine/threonine-protein kinase PIM1 | T50594 | SwissTargetPrediction |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | T70176 | SwissTargetPrediction |
| Q9P1W9 | PIM2 | Serine/threonine-protein kinase PIM2 | T07279 | SwissTargetPrediction |
| Q13535 | ATR | Serine-protein kinase ATR | T97155 | SwissTargetPrediction |
| O14965 | AURKA | Serine/threonine-protein kinase Aurora-A | T87675 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P30559 | OXTR | Oxytocin receptor (by homology) | T84486 | SwissTargetPrediction |
| P37288 | AVPR1A | Vasopressin V1a receptor (by homology) | T79232 | SwissTargetPrediction |
| O43603 | GALR2 | Galanin receptor 2 (by homology) | T13453 | SwissTargetPrediction |
| P47211 | GALR1 | Galanin receptor 1 (by homology) | T78581 | SwissTargetPrediction |
| P00742 | F10 | Thrombin and coagulation factor X | T84631 | SwissTargetPrediction |
| O14746 | TERT | Telomerase reverse transcriptase | T86052 | SwissTargetPrediction |
| Q08499 | PDE4D | Phosphodiesterase 4D | T02001 | SwissTargetPrediction |
| P49356 | FNTB | Farnesyl protein transferase | T13127 | SwissTargetPrediction |
| P04035 | HMGCR | HMG-CoA reductase | T53585 | SwissTargetPrediction |
| P23458 | JAK1 | Tyrosine-protein kinase JAK1 | T62460 | SwissTargetPrediction |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | T70977 | SwissTargetPrediction |
| P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | T96623 | SwissTargetPrediction |
| P32246 | CCR1 | C-C chemokine receptor type 1 | T16016 | SwissTargetPrediction |
| P05771 | PRKCB | Protein kinase C beta | T40276 | SwissTargetPrediction |
| Q02156 | PRKCE | Protein kinase C epsilon | T00895 | SwissTargetPrediction |
| Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | T99057 | SwissTargetPrediction |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SwissTargetPrediction |
| Q99572 | P2RX7 | P2X purinoceptor 7 | T63414 | SwissTargetPrediction |
| Q15078 | CDK5R1 | Cyclin-dependent kinase 5/CDK5 activator 1 | T09513 | SwissTargetPrediction |
| P29466 | CASP1 | Caspase-1 | T98269 | SwissTargetPrediction |
| P12931 | SRC | Tyrosine-protein kinase SRC | T85943 | SwissTargetPrediction |
| Q13627 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | T92803 | SwissTargetPrediction |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction |
| P48039 | MTNR1A | Melatonin receptor 1A | T97613 | SwissTargetPrediction |
| P49286 | MTNR1B | Melatonin receptor 1B | T48268 | SwissTargetPrediction |
| Q05655 | PRKCD | Protein kinase C delta | T44861 | SwissTargetPrediction |
| P28482 | MAPK1 | MAP kinase ERK2 | T58970 | SwissTargetPrediction |
| P06493 | CDK1 | Cyclin-dependent kinase 1/cyclin B1 | T49898 | SwissTargetPrediction |
| P25024 | CXCR1 | Interleukin-8 receptor A | T00884 | SwissTargetPrediction |
| P07333 | CSF1R | Macrophage colony stimulating factor receptor | T20333 | SwissTargetPrediction |
| P04629 | NTRK1 | Nerve growth factor receptor Trk-A | T07173 | SwissTargetPrediction |
| P50750 | CDK9 | Cyclin-dependent kinase 9 | T44458 | SwissTargetPrediction |
| P06737 | PYGL | Liver glycogen phosphorylase | T19184 | SwissTargetPrediction |
| P25025 | CXCR2 | Interleukin-8 receptor B | T56923 | SwissTargetPrediction |
| P11597 | CETP | Cholesteryl ester transfer protein | T15334 | SwissTargetPrediction |
| P42574 | CASP3 | Caspase-3 | T57943 | SwissTargetPrediction |
| P55210 | CASP7 | Caspase-7 | T72252 | SwissTargetPrediction |
| P41146 | OPRL1 | Nociceptin receptor | T52921 | SwissTargetPrediction |
| Q99835 | SMO | Smoothened homolog | T66505 | SwissTargetPrediction |
| Q00987 | MDM2 | p53-binding protein Mdm-2 | T00176 | SwissTargetPrediction |
| P55212 | CASP6 | Caspase-6 | T20600 | SwissTargetPrediction |
| Q9UQ81 | MCH5 | Caspase-8 | T15700 | SwissTargetPrediction |
| Q13976 | PRKG1 | cGMP-dependent protein kinase 1 beta | T78543 | SwissTargetPrediction |
| Q04759 | PRKCQ | Protein kinase C theta | T23995 | SwissTargetPrediction |
| P08151 | GLI1 | Zinc finger protein GLI1 | T40890 | SEA |
| P53350 | PLK1 | Serine/threonine-protein kinase PLK1 | T40694 | SwissTargetPrediction |
| Q16602 | CALCRL | Calcitonin gene-related peptide type 1 receptor | T02226 | SwissTargetPrediction |
| Q96GD4 | AURKB | Serine/threonine-protein kinase Aurora-B | T46781 | SwissTargetPrediction |
| O43614 | HCRTR2 | Orexin receptor 2 | T69485 | SwissTargetPrediction |
| O43613 | HCRTR1 | Orexin receptor 1 | T73482 | SwissTargetPrediction |
| P53609 | PGGT1B | Geranylgeranyl transferase type I | T76396 | SwissTargetPrediction |
| P01584 | IL1B | Interleukin-1 beta | T42000 | SwissTargetPrediction |
| Q16549 | PCSK7 | Subtilisin/kexin type 7 | T33211 | SwissTargetPrediction |
| P00746 | CFD | Complement factor D | T66383 | SwissTargetPrediction |
| Q9NR97 | TLR8 | Toll-like receptor 8 | T48703 | SwissTargetPrediction |
| P40337 | VHL | Von Hippel-Lindau disease tumor suppressor/Elongin B/Elongin C | T80423 | SwissTargetPrediction |
| P05129 | PRKCG | Protein kinase C gamma | T47107 | SwissTargetPrediction |
| Q9NYK1 | TLR7 | Toll-like receptor (TLR7/TLR9) | T46482 | SwissTargetPrediction |
| Q9HBA0 | TRPV4 | Transient receptor potential cation channel subfamily V member 4 | T64213 | SwissTargetPrediction |
| P41252 | IARS | Isoleucyl-tRNA synthetase | T46515 | SwissTargetPrediction |
| Q9Y337 | KLK5 | Kallikrein 5 | T11808 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T17980 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P06241 | FYN |
| T59328 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00533 | EGFR |
| T59328 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00533 | EGFR |
| T59328 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P00533 | EGFR |
| T59328 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P00533 | EGFR |
| T59328 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00533 | EGFR |
| T59328 | DI0238 | Lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P00533 | EGFR |
| T59328 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00533 | EGFR |
| T59328 | DI0420 | Unspecific body region injury | [ICD-11: ND56] | P00533 | EGFR |
| T77365 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P29274 | ADORA2A |
| T77365 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P29274 | ADORA2A |
| T77365 | DI0359 | Radionuclide imaging | [ICD-11: N.A.] | P29274 | ADORA2A |
| T06273 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P09874 | PARP1 |
| T06273 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | P09874 | PARP1 |
| T06273 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P09874 | PARP1 |
| T06273 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P09874 | PARP1 |
| T61622 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P00797 | REN |
| T99347 | DI0152 | Fragile X chromosome | [ICD-11: LD55] | P41594 | GRM5 |
| T99347 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P41594 | GRM5 |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T35734 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P34913 | EPHX2 |
| T35734 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P34913 | EPHX2 |
| T32060 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P28223 | HTR2A |
| T32060 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P28223 | HTR2A |
| T32060 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P28223 | HTR2A |
| T32060 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P28223 | HTR2A |
| T32060 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P28223 | HTR2A |
| T32060 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28223 | HTR2A |
| T32060 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28223 | HTR2A |
| T66665 | DI0087 | Chronic pain | [ICD-11: MG30] | P35354 | PTGS2 |
| T66665 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P35354 | PTGS2 |
| T66665 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P35354 | PTGS2 |
| T66665 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P35354 | PTGS2 |
| T66665 | DI0227 | Knee osteoarthritis | [ICD-11: FA01] | P35354 | PTGS2 |
| T66665 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35354 | PTGS2 |
| T66665 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35354 | PTGS2 |
| T66665 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P35354 | PTGS2 |
| T66665 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | P35354 | PTGS2 |
| T11211 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P10275 | AR |
| T11211 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10275 | AR |
| T11211 | DI0021 | Alcoholic liver disease | [ICD-11: DB94] | P10275 | AR |
| T11211 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10275 | AR |
| T11211 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P10275 | AR |
| T11211 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P10275 | AR |
| T11211 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P10275 | AR |
| T11211 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P10275 | AR |
| T11211 | DI0247 | Mammary tumour | [ICD-11: 2C60-2C6Z] | P10275 | AR |
| T11211 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P10275 | AR |
| T11211 | DI0401 | Testicular dysfunction | [ICD-11: 5A81] | P10275 | AR |
| T40097 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45983 | MAPK8 |
| T72168 | DI0018 | Adrenocortical insufficiency | [ICD-11: 5A74] | P08235 | NR3C2 |
| T72168 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P08235 | NR3C2 |
| T72168 | DI0100 | Contraceptive management | [ICD-11: QA21] | P08235 | NR3C2 |
| T72168 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08235 | NR3C2 |
| T72168 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08235 | NR3C2 |
| T72168 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P08235 | NR3C2 |
| T40016 | DI0016 | Adaptive immunity immunodeficiency | [ICD-11: 4A01] | P04150 | NR3C1 |
| T40016 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P04150 | NR3C1 |
| T40016 | DI0037 | Asthma | [ICD-11: CA23] | P04150 | NR3C1 |
| T40016 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P04150 | NR3C1 |
| T40016 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P04150 | NR3C1 |
| T40016 | DI0280 | Muscular dystrophy | [ICD-11: 8C70] | P04150 | NR3C1 |
| T40016 | DI0314 | Oesophagitis | [ICD-11: DA24] | P04150 | NR3C1 |
| T40016 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P04150 | NR3C1 |
| T40016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P04150 | NR3C1 |
| T40016 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04150 | NR3C1 |
| T40016 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | P04150 | NR3C1 |
| T22939 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06401 | PGR |
| T22939 | DI0100 | Contraceptive management | [ICD-11: QA21] | P06401 | PGR |
| T22939 | DI0255 | Menstrual cycle bleeding disorder | [ICD-11: GA20] | P06401 | PGR |
| T22939 | DI0344 | Preterm labour/delivery | [ICD-11: JB00] | P06401 | PGR |
| T22939 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06401 | PGR |
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T67102 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P07339 | CTSD |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T65200 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P28845 | HSD11B1 |
| T65200 | DI0239 | Lupus erythematosus | [ICD-11: 4A40] | P28845 | HSD11B1 |
| T65200 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P28845 | HSD11B1 |
| T06958 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06746 | POLB |
| T86702 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P08254 | MMP3 |
| T86702 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P08254 | MMP3 |
| T86702 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P08254 | MMP3 |
| T86702 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P08254 | MMP3 |
| T86702 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P08254 | MMP3 |
| T86702 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P08254 | MMP3 |
| T86702 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P08254 | MMP3 |
| T48069 | DI0276 | Multiple structural anomalies syndrome | [ICD-11: LD2F] | P08069 | IGF1R |
| T48069 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P08069 | IGF1R |
| T48069 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P08069 | IGF1R |
| T02551 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P35462 | DRD3 |
| T02551 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35462 | DRD3 |
| T50594 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11309 | PIM1 |
| T50594 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11309 | PIM1 |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T70176 | DI0060 | Brain cancer | [ICD-11: 2A00] | P24941 | CDK2 |
| T70176 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P24941 | CDK2 |
| T70176 | DI0238 | Lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P24941 | CDK2 |
| T70176 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P24941 | CDK2 |
| T70176 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P24941 | CDK2 |
| T70176 | DI0406 | Thymoma | [ICD-11: 2C27] | P24941 | CDK2 |
| T07279 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9P1W9 | PIM2 |
| T07279 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9P1W9 | PIM2 |
| T97155 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q13535 | ATR |
| T97155 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q13535 | ATR |
| T97155 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | Q13535 | ATR |
| T97155 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q13535 | ATR |
| T87675 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O14965 | AURKA |
| T87675 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14965 | AURKA |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T84486 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P30559 | OXTR |
| T84486 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P30559 | OXTR |
| T84486 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P30559 | OXTR |
| T79232 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P37288 | AVPR1A |
| T79232 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P37288 | AVPR1A |
| T79232 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P37288 | AVPR1A |
| T79232 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P37288 | AVPR1A |
| T79232 | DI0236 | Localisation | [ICD-11: N.A.] | P37288 | AVPR1A |
| T78581 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P47211 | GALR1 |
| T84631 | DI0053 | Blood-forming organ disease | [ICD-11: 3C0Z] | P00742 | F10 |
| T84631 | DI0080 | Christmas disease | [ICD-11: 3B11] | P00742 | F10 |
| T84631 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P00742 | F10 |
| T84631 | DI0103 | Coronary thrombosis | [ICD-11: BA43] | P00742 | F10 |
| T84631 | DI0114 | Deep vein thrombosis | [ICD-11: BD71] | P00742 | F10 |
| T84631 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P00742 | F10 |
| T84631 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P00742 | F10 |
| T84631 | DI0433 | Venous thromboembolism | [ICD-11: BD72] | P00742 | F10 |
| T86052 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | O14746 | TERT |
| T86052 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O14746 | TERT |
| T86052 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14746 | TERT |
| T02001 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | Q08499 | PDE4D |
| T13127 | DI0342 | Premature ageing appearance | [ICD-11: LD2B] | P49356 | FNTB |
| T53585 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P04035 | HMGCR |
| T53585 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P04035 | HMGCR |
| T53585 | DI0128 | Dyslipidemia | [ICD-11: 5C80-5C81] | P04035 | HMGCR |
| T53585 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P04035 | HMGCR |
| T53585 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P04035 | HMGCR |
| T53585 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P04035 | HMGCR |
| T53585 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P04035 | HMGCR |
| T62460 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23458 | JAK1 |
| T62460 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P23458 | JAK1 |
| T62460 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P23458 | JAK1 |
| T62460 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | P23458 | JAK1 |
| T70977 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | P49841 | GSK3B |
| T96623 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P08238 | HSP90AB1 |
| T96623 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08238 | HSP90AB1 |
| T96623 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P08238 | HSP90AB1 |
| T96623 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P08238 | HSP90AB1 |
| T96623 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P08238 | HSP90AB1 |
| T96623 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P08238 | HSP90AB1 |
| T96623 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P08238 | HSP90AB1 |
| T16016 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P32246 | CCR1 |
| T16016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P32246 | CCR1 |
| T40276 | DI0123 | Diffuse large B-cell lymphoma | [ICD-11: 2A81] | P05771 | PRKCB |
| T40276 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P05771 | PRKCB |
| T40276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P05771 | PRKCB |
| T00895 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | Q02156 | PRKCE |
| T00895 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | Q02156 | PRKCE |
| T99057 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | Q02750 | MAP2K1 |
| T99057 | DI0336 | Phakomatoses/hamartoneoplastic syndrome | [ICD-11: LD2D] | Q02750 | MAP2K1 |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T63414 | DI0224 | Joint pain | [ICD-11: ME82] | Q99572 | P2RX7 |
| T98269 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P29466 | CASP1 |
| T98269 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | P29466 | CASP1 |
| T98269 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P29466 | CASP1 |
| T98269 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P29466 | CASP1 |
| T85943 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P12931 | SRC |
| T85943 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P12931 | SRC |
| T85943 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P12931 | SRC |
| T85943 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P12931 | SRC |
| T92803 | DI0113 | Cytomegaloviral disease | [ICD-11: 1D82] | Q13627 | DYRK1A |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T97613 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P48039 | MTNR1A |
| T48268 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P49286 | MTNR1B |
| T44861 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q05655 | PRKCD |
| T58970 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P28482 | MAPK1 |
| T58970 | DI0252 | Melanoma | [ICD-11: 2C30] | P28482 | MAPK1 |
| T58970 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P28482 | MAPK1 |
| T58970 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28482 | MAPK1 |
| T49898 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06493 | CDK1 |
| T49898 | DI0238 | Lung cancer | [ICD-11: 2C25] | P06493 | CDK1 |
| T49898 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P06493 | CDK1 |
| T49898 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P06493 | CDK1 |
| T49898 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06493 | CDK1 |
| T00884 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P25024 | CXCR1 |
| T20333 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P07333 | CSF1R |
| T07173 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P04629 | NTRK1 |
| T07173 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04629 | NTRK1 |
| T44458 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P50750 | CDK9 |
| T44458 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P50750 | CDK9 |
| T44458 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P50750 | CDK9 |
| T44458 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P50750 | CDK9 |
| T44458 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P50750 | CDK9 |
| T44458 | DI0302 | Non-alcoholic fatty liver disease | [ICD-11: DB92] | P50750 | CDK9 |
| T44458 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P50750 | CDK9 |
| T56923 | DI0155 | Fungal infection | [ICD-11: 1F29-1F2F] | P25025 | CXCR2 |
| T56923 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P25025 | CXCR2 |
| T15334 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | P11597 | CETP |
| T15334 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P11597 | CETP |
| T15334 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P11597 | CETP |
| T15334 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P11597 | CETP |
| T57943 | DI0060 | Brain cancer | [ICD-11: 2A00] | P42574 | CASP3 |
| T72252 | DI0110 | Cystic fibrosis | [ICD-11: CA25] | P55210 | CASP7 |
| T52921 | DI0039 | Atopic eczema | [ICD-11: EA80] | P41146 | OPRL1 |
| T52921 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41146 | OPRL1 |
| T52921 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P41146 | OPRL1 |
| T52921 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P41146 | OPRL1 |
| T66505 | DI0047 | Basal cell carcinoma | [ICD-11: 2C32] | Q99835 | SMO |
| T66505 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | Q99835 | SMO |
| T66505 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q99835 | SMO |
| T00176 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q00987 | MDM2 |
| T00176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q00987 | MDM2 |
| T15700 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | Q9UQ81 | MCH5 |
| T15700 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UQ81 | MCH5 |
| T23995 | DI0413 | Transplant rejection | [ICD-11: NE84] | Q04759 | PRKCQ |
| T40694 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P53350 | PLK1 |
| T40694 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P53350 | PLK1 |
| T40694 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P53350 | PLK1 |
| T46781 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q96GD4 | AURKB |
| T46781 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q96GD4 | AURKB |
| T69485 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43614 | HCRTR2 |
| T73482 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O43613 | HCRTR1 |
| T73482 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43613 | HCRTR1 |
| T73482 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | O43613 | HCRTR1 |
| T76396 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P53609 | PGGT1B |
| T42000 | DI0267 | Mineral excesses | [ICD-11: 5B91] | P01584 | IL1B |
| T42000 | DI0269 | Monogenic autoinflammatory syndrome | [ICD-11: 4A60] | P01584 | IL1B |
| T42000 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P01584 | IL1B |
| T42000 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P01584 | IL1B |
| T66383 | DI0170 | Haemolytic anemia | [ICD-11: 3A20-3A2Z] | P00746 | CFD |
| T66383 | DI0365 | Retinopathy | [ICD-11: 9B71] | P00746 | CFD |
| T48703 | DI0133 | Epidermal dysplasias | [ICD-11: EK90] | Q9NR97 | TLR8 |
| T48703 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | Q9NR97 | TLR8 |
| T48703 | DI0180 | Herpes simplex infection | [ICD-11: 1F00] | Q9NR97 | TLR8 |
| T48703 | DI0239 | Lupus erythematosus | [ICD-11: 4A40] | Q9NR97 | TLR8 |
| T48703 | DI0252 | Melanoma | [ICD-11: 2C30] | Q9NR97 | TLR8 |
| T48703 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | Q9NR97 | TLR8 |
| T48703 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9NR97 | TLR8 |
| T48703 | DI0393 | Squamous cell carcinoma | [ICD-11: 2B60-2D01] | Q9NR97 | TLR8 |
| T48703 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q9NR97 | TLR8 |
| T47107 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P05129 | PRKCG |
| T47107 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P05129 | PRKCG |
| T46482 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | Q9NYK1 | TLR7 |
| T46482 | DI0384 | Skin disease | [ICD-11: EA00-EM0Z] | Q9NYK1 | TLR7 |
| T64213 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q9HBA0 | TRPV4 |
| T64213 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q9HBA0 | TRPV4 |
| T64213 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | Q9HBA0 | TRPV4 |